Deep Pocket Exploration

A modification to traditional docking software enables the examination of a ligand’s passage into its receptor.

Feb 1, 2017
Ruth Williams

MOLECULAR SPELUNKING: AutoDock Vina evaluates a receptor’s entire binding pocket at once to find a docking site (lowest-energy binding) for a ligand of interest. The deepest part of the pocket (the actual binding site for auxin shown at the bottom of (1) naturally has a low energy requirement, and this is where, in the case of tryptophan (2), the software suggests a docking site. But by forcing the software to move in incremental steps—starting at the mouth of the pocket and moving inward—TomoDock finds an interaction of tryptophan with residues farther up the pocket (3) that prevents deeper entry. In the case of auxin, however, TomoDock finds the same binding site as that found using AutoDock Vina (step-wise progress of TomoDock shown in (1).© GEORGE RETSECK

Auxins are a family of small-molecule hormones that control growth and development processes in plants. They are also components of widely used herbicides. In a drive to extend the agricultural and horticultural applications of these hormones, scientists are attempting to design new synthetic auxins. But to do so, they must understand the nitty-gritty of how an auxin molecule binds to it receptor, says Richard Napier of the University of Warwick in the U.K.

Napier’s team uses docking software to simulate auxin binding. But there’s a problem: the software also allows molecules to dock that, Napier says, are known not to bind in reality—such as auxin’s close relative tryptophan. “Getting false positives out of docking [analyses] is absolutely part of the deal,” he says. “Docking is not a perfect science.”

To reduce such permissiveness, Napier and his colleagues have written additional computational code for a popular docking program, AutoDock Vina. For receptors with deep binding-site pockets (like that of the auxin receptor), the new code mimics the molecule’s natural passage by searching for the docking site in a sequence of 0.1-nanometer steps.

Drawing an analogy with a cave, Ning Zheng of the University of Washington says, “The conventional [docking] method just looks at whether a child or adult can be accommodated by the cave interior, but if that cave is separated from the outside by, let’s say, a narrow cleft, then . . . maybe it turns out the adult is too big to pass [through].”

Restriction of a molecule’s access may not be due to size, but to interactions with residues on the “cave” walls as it enters—which is the case for tryptophan, Napier’s team has now discovered. Without simulating a molecule’s passage, as per the new method, called TomoDock, such interactions can be missed, Napier says. (Open Biology, 6:160139, 2016) 

AutoDock Vina A 3-D cuboidal area encompassing the entire binding pocket of a receptor All ligand-receptor interactions Free to download from
TomoDock (with AutoDock Vina) A 3-D cuboidal area big enough to encompass the entire binding pocket, but which is initially positioned at the mouth of the binding pocket and then moved stepwise into the pocket in small increments Specifically for receptors with deep binding pockets or transport proteins in which molecules of interest pass though a channel Free to download from


January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb


Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.